Score 8.1 (out of 10): PFIZER sets up for +9.7% rally in 2 months


What’s Going On Here?

Health Canada approved Pfizer’s COVID-19 vaccine today for use in children between six months and four years old.

Why Now?

PFIZER has triggered a new technical analysis ‘rally reversal’ signal. During similar occasions, PFIZER shares had a median return of +9.7%, over the following 2 months – based on 10 historical occasions with 9 of those showing positive returns (90%). This buy signal for PFIZER received a high score of 8.1 (out of 10). This insight was generated on 2022-September-9 with last price of 47.84.

What’s This Token About?

PFIZER is in the Medical-Drugs business. Based on the last 2 years’ risk/return profile, this asset is seen as Moderate Risk. Ticker symbol: PFE US.

What’s My Risk / Reward and Time Horizon?

We found 2 months to be the optimal trade horizon, after testing a number of possible alternatives (accuracy of previous returns). Otherwise consider closing out this trade once the target level of 52.46 (+9.7%) has been reached. Based on PFIZER’s recent up and down swings, LongShortBets suggests considering to set a stop loss level for this insight at 46.44 (last price at 47.84), which is equivalent to a -2.9% decline.

Returns during similar periods:

The chart above shows the previous returns (in %) based on similar setups with the most recent ‘insight’ shown under (1), the second most recent ‘insight’ under (2), etc.

Previous episodes:

4.1% (January-2022), 46.2% (October-2021), 26.9% (June-2021), 13.8% (February-2021), -4.7% (December-2020), 8.8% (August-2020), 10.4% (June- 2020), 24.8% (February-2020), 8.9% (July-2019), 1.1% (February-2019).

Historical Chart:


Star (1 to 10)8.1
Time2 months
Hit Rate90%

Leave a Reply